167 related articles for article (PubMed ID: 35078668)
1. Race and ethnic representation among clinical trials for diabetic retinopathy and diabetic macular edema within the United States: A review.
Sanjiv N; Osathanugrah P; Harrell M; Siegel NH; Ness S; Chen X; Cabral H; Subramanian ML
J Natl Med Assoc; 2022 Apr; 114(2):123-140. PubMed ID: 35078668
[TBL] [Abstract][Full Text] [Related]
2. Representation of Race and Ethnicity in Randomized Clinical Trials of Diabetic Macular Edema and Retinal Vein Occlusion Compared to 2010 US Census Data.
Kaakour AH; Hua HU; Rachitskaya A
JAMA Ophthalmol; 2022 Nov; 140(11):1096-1102. PubMed ID: 36201192
[TBL] [Abstract][Full Text] [Related]
3. Racial and Ethnic Distribution in Diabetic Macular Edema Clinical Trials in the United States (2002-2021).
Yu AJ; Masalkhi M; Brown R; Chen B; Chhablani J
Ophthalmol Retina; 2023 Dec; 7(12):1035-1041. PubMed ID: 37479084
[TBL] [Abstract][Full Text] [Related]
4. Racial, Ethnic, and Insurance-Based Disparities Upon Initiation of Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in the US.
Malhotra NA; Greenlee TE; Iyer AI; Conti TF; Chen AX; Singh RP
Ophthalmology; 2021 Oct; 128(10):1438-1447. PubMed ID: 33716048
[TBL] [Abstract][Full Text] [Related]
5. Racial, Ethnic, and Gender Disparities in Diabetic Macular Edema Clinical Trials.
Bowe T; Salabati M; Soares RR; Huang C; Singh RP; Khan MA; Williams BK; Sridhar J; Chiang A; Cohen MN; Klufas MA; Gupta OP; Yonekawa Y; Xu D; Kuriyan AE
Ophthalmol Retina; 2022 Jun; 6(6):531-533. PubMed ID: 35131526
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Diabetic Retinopathy in the US in 2021.
Lundeen EA; Burke-Conte Z; Rein DB; Wittenborn JS; Saaddine J; Lee AY; Flaxman AD
JAMA Ophthalmol; 2023 Aug; 141(8):747-754. PubMed ID: 37318810
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of and risk factors for diabetic macular edema in the United States.
Varma R; Bressler NM; Doan QV; Gleeson M; Danese M; Bower JK; Selvin E; Dolan C; Fine J; Colman S; Turpcu A
JAMA Ophthalmol; 2014 Nov; 132(11):1334-40. PubMed ID: 25125075
[TBL] [Abstract][Full Text] [Related]
8. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes.
Fenwick EK; Xie J; Ratcliffe J; Pesudovs K; Finger RP; Wong TY; Lamoureux EL
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):677-84. PubMed ID: 22205611
[TBL] [Abstract][Full Text] [Related]
9. Differential Impact of Unilateral and Bilateral Classifications of Diabetic Retinopathy and Diabetic Macular Edema on Vision-Related Quality of Life.
Man RE; Fenwick EK; Sabanayagam C; Li LJ; Tey CS; Soon HJ; Cheung GC; Tan GS; Wong TY; Lamoureux EL
Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4655-60. PubMed ID: 27603726
[TBL] [Abstract][Full Text] [Related]
10. The relationship between peripheral blood inflammatory markers and diabetic macular edema in patients with severe diabetic retinopathy.
Zhu Y; Cai Q; Li P; Zhou Y; Xu M; Song Y
Ann Palliat Med; 2022 Mar; 11(3):984-992. PubMed ID: 35365028
[TBL] [Abstract][Full Text] [Related]
11. Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumab.
Baget-Bernaldiz M; Romero-Aroca P; Bautista-Perez A; Mercado J
Doc Ophthalmol; 2017 Oct; 135(2):85-96. PubMed ID: 28779336
[TBL] [Abstract][Full Text] [Related]
12. Optical coherence tomography for the detection of early macular edema in diabetic patients with retinopathy.
Koleva-Georgieva DN; Sivkova NP
Folia Med (Plovdiv); 2010; 52(1):40-8. PubMed ID: 20380286
[TBL] [Abstract][Full Text] [Related]
13. United States comparative costs and absenteeism of diabetic ophthalmic conditions.
Brook RA; Kleinman NL; Patel S; Smeeding JE; Beren IA; Turpcu A
Postgrad Med; 2015 Jun; 127(5):455-62. PubMed ID: 25549691
[TBL] [Abstract][Full Text] [Related]
14. Can the Future be Bright with Advances in Diabetic Eye Care?
Paul S; Kim C; Soliman MK; Sobol W; Echegaray JJ; Kurup S
Endocrinol Metab Clin North Am; 2023 Mar; 52(1):89-99. PubMed ID: 36754499
[TBL] [Abstract][Full Text] [Related]
15. Algorithms for Diagnosis of Diabetic Retinopathy and Diabetic Macula Edema- A Review.
Suriyasekeran K; Santhanamahalingam S; Duraisamy M
Adv Exp Med Biol; 2021; 1307():357-373. PubMed ID: 32166636
[TBL] [Abstract][Full Text] [Related]
16. Diabetic retinopathy, diabetic macular edema, and cardiovascular risk: the importance of a long-term perspective and a multidisciplinary approach to optimal intravitreal therapy.
Bandello F; Toni D; Porta M; Varano M
Acta Diabetol; 2020 May; 57(5):513-526. PubMed ID: 31749046
[TBL] [Abstract][Full Text] [Related]
17. [Severity of diabetic macular edema (DME) in Seine St Denis among patients treated by anti-VEGF].
Stéphan S; Fajnkuchen F; Addou-Regnard M; Grenet T; Nghiem-Buffet S; Chaine G; Giocanti-Auregan A
J Fr Ophtalmol; 2014 Nov; 37(9):717-21. PubMed ID: 25308789
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in the screening and treatment of diabetic retinopathy.
Coney JM; Scott AW
J Natl Med Assoc; 2022 Apr; 114(2):171-181. PubMed ID: 35105457
[TBL] [Abstract][Full Text] [Related]
19. Ranibizumab for the treatment of diabetic retinopathy.
Chatziralli I
Expert Opin Biol Ther; 2021 Aug; 21(8):991-997. PubMed ID: 33966556
[No Abstract] [Full Text] [Related]
20. Evidence-Based Treatment of Diabetic Macular Edema.
Barham R; El Rami H; Sun JK; Silva PS
Semin Ophthalmol; 2017; 32(1):56-66. PubMed ID: 28060586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
